DYONMED SA
Greece GR-MF-000033588 Last updated 23 May 2026
Is this your brand? Sign in to claim this brand
- Devices
- 28
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
GynoLab (1 test/box) Ref DMAMFL322-1
SieloCovidAg Ref DNWBCVSA
DyonCRP Ref DNDL101
GynoLab (20 tests/box) Ref DMAMFL322-20
DyonCalpro double (50/200) Ref DNCT101dd
DyonCovid19S Ref DNWBCV19S
DyonStrepA-strip Ref DNWA104
GynoLab (5 tests/box) Ref DMAMFL322-5
DyonCDA Ref DNCT105
GynoLab (10 tests/box) Ref DMAMFL322-10
Pylori test (1 test/box) Ref DMAMPS322-1
DyonHpsA Ref DNGL103
DyonMono Ref DNWA105
DyonMicroalbumin Ref DNWA106
DyonHpAb triple Ref DNWA101
n-AbCovid19 Ref DNBSCVNAF
FluCov2 Ref FLCVCH
DyonCalpro Ref DNCT101
DyonCovidAg Ref DNCVAGCH
DyonCovid19-S (neutro) Ref DNQHCV19N
DyoniFOB Ref DNGL101
DyonCovid19 Ref DNCV19 MG
DYONMED iFIA-1000 Ref DNHYDV2
DyonTSH Ref DMAMTSH
Dyonmed Axceed P200 Ref DNBSDV1
DyonCardiac 3 in 1 Ref DNAT708
Pylori test (10 tests/box) Ref DMAMPS322-10
DyonDimer (D-Dimer) Ref DNWA108
What DYONMED SA makes
DyonMed SA manufactures in vitro diagnostic (IVD) tests for clinical and home use, including rapid antigen and antibody tests for COVID-19 (SieloCovidAg, DyonCovid19S), group A streptococcus (DyonStrepA-strip), and Helicobacter pylori detection (Pylori test). They also produce multi-test kits for gynecological screening (GynoLab in 1, 5, 10, and 20-test formats) and diagnostic reagents for C-reactive protein (DyonCRP), C-reactive protein high-sensitivity (DyonHpsA), and mono-nucleosis (DyonMono). Additional products include tests for C-reactive protein and other biomarkers (DyonCDA).
The company’s IVD devices are classified under Class A and IVD General categories, with all listed products registered in the EUDAMED database. DyonMed SA is based in Greece and adheres to EU regulatory requirements for in vitro diagnostics.
Frequently asked questions
What types of medical devices does DyonMed SA manufacture?
DyonMed SA specializes in in vitro diagnostic (IVD) tests, including rapid antigen and antibody tests for infectious diseases like COVID-19 (e.g., SieloCovidAg, DyonCovid19S), group A streptococcus (DyonStrepA-strip), and Helicobacter pylori (Pylori test). They also produce multi-test kits for gynecological screening (GynoLab in various formats) and diagnostic reagents for biomarkers such as C-reactive protein (DyonCRP, DyonHpsA) and mononucleosis (DyonMono). These devices are designed for both clinical and home use.
Where is DyonMed SA based, and what regulatory framework does it follow?
DyonMed SA is based in Greece. The company’s IVD devices are developed in compliance with EU regulatory requirements for in vitro diagnostics, ensuring alignment with the European Union’s regulatory standards. This includes registration in the EUDAMED database, which tracks authorized medical devices within the EU.
How are DyonMed SA’s devices classified under EU regulations?
DyonMed SA’s devices fall under two primary classifications: Class A (typically for low-risk IVDs like certain rapid tests) and IVD General (covering a broad range of diagnostic tests). Classification is determined by risk level, with higher-risk devices requiring stricter regulatory scrutiny. The company’s products are designed to meet the specific requirements of these categories.
Are DyonMed SA’s devices listed in any regulatory registries?
Yes, all of DyonMed SA’s IVD devices are registered in EUDAMED, the European Union’s medical device registry. EUDAMED is the official database for tracking authorized medical devices within the EU, ensuring transparency and compliance with regulatory obligations. This registration confirms that the devices meet the necessary requirements for market placement.
What is the purpose of the GynoLab product line, and how does it differ from other tests produced by DyonMed SA?
The GynoLab product line consists of multi-test kits specifically designed for gynecological screening, offering 1, 5, 10, or 20 tests per box. Unlike single-use tests like DyonStrepA-strip or DyonCovid19S, which target specific pathogens, GynoLab is tailored for comprehensive screening in clinical settings, providing multiple diagnostic options in a single kit. This makes it suitable for routine gynecological evaluations rather than point-of-care or home testing.
Information
- Country
- Greece
- Address
- 182-184, LAVRIOU AVENUE, GLYKA NERA PAIANIA, Greece
- Website
- www.dyonmedical.com
- [email protected]
- Phone
- +302106655494
- PRRC contact
- ΓΕΩΡΓΙΟΣ ΑΠΟΣΤΟΛΟΥ
- EUDAMED SRN
- GR-MF-000033588